▲ +3.39% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Semler Scientific in the last 3 months. The average price target is $110.50, with a high forecast of $121.00 and a low forecast of $100.00. The average price target represents a 3.39% upside from the last price of $106.88.
The current consensus among 2 polled investment analysts is to buy stock in Semler Scientific.
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was founded in 2007 and is based in Santa Clara, California.